Drug Targeting HLC-1: A Promising Approach for Various Diseases

Target Name: NDUFC2

NCBI ID: G4718

NDUFC2

Drug Targeting HLC-1: A Promising Approach for Various Diseases

National Development Unit-Food and Agriculture Organization (NDUFC2) is a protein that plays a vital role in the development and progression of various diseases, including cancer. The protein is a key component of the cell membrane and is involved in various cellular processes, including cell signaling, migration, and invasion. Its functions make it an attractive drug target or biomarker for various diseases.

The National Development Unit (NDU) is a part of the National Research Council (NRC) in Canada and is dedicated to the development of new technologies and products for the benefit of society. The NDUFC2 protein is one of the many promising proteins that the NDU has identified for potential drug development.

The HLC-1 protein

HLC-1 is a 21-kDa protein that is expressed in most tissues of the body. It is a key component of the cell membrane and is involved in various cellular processes, including cell signaling, migration, and invasion. The HLC-1 protein plays a vital role in the regulation of cellular processes that are essential for the growth, development, and survival of all living organisms.

The HLC-1 protein is composed of two distinct regions: an N-terminal region and a C-terminal region. The N-terminal region contains a unique cal hydrophobic domain that is known to be involved in various cellular processes. The C-terminal region region contains a transmembrane domain and a unique farnesylated cysteine 鈥嬧?媟esidue that is known to be involved in various cellular processes.

The HLC-1 protein is involved in various cellular processes, including cell signaling, migration, and invasion. It is a key component of the cell membrane and is involved in the regulation of various cellular processes that are essential for the growth, development, and survival of all living organisms.

Drug targeting HLC-1

Drug targeting HLC-1 is an attractive approach for the development of new pharmaceuticals for various diseases. The HLC-1 protein is involved in various cellular processes that are essential for the growth, development, and survival of all living organisms, making it an attractive drug target for various diseases.

One of the main advantages of drug targeting HLC-1 is its targeted nature. The HLC-1 protein is expressed in most tissues of the body and is involved in various cellular processes that are essential for the growth, development, and survival of all living organisms. This makes it an attractive drug target for diseases that affect the development, growth, and survival of various organisms.

Another advantage of drug targeting HLC-1 is its potential to target a range of diseases. The HLC-1 protein is involved in various cellular processes that are essential for the growth, development, and survival of all living organisms. This makes it an attractive drug target for diseases that affect the development, growth, and survival of various organisms.

The HLC-1 protein is also a good candidate for drug targeting due to its unique structure. The HLC-1 protein is composed of two distinct regions: an N-terminal region and a C-terminal region. The N-terminal region contains a unique cal hydrophobic domain that is known to be involved in various cellular processes. The C-terminal region contains a transmembrane domain and a unique farnesylated cysteine 鈥嬧?媟esidue that is known to be involved in various cellular processes.

Biomarker potential

The HLC-1 protein is also a promising biomarker for various diseases. Its involvement in various cellular processes makes it an attractive biomarker for diseases that affect the development, growth, and survival of various organisms. for drug targeting due to its unique structure, which makes it potential to target a range of diseases.

The HLC-1 protein is involved in

Protein Name: NADH:ubiquinone Oxidoreductase Subunit C2

Functions: Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis but required for the complex assembly. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone

The "NDUFC2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NDUFC2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets